Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

The drug is indicated for the treatment of schizophrenia and for additional maintenance treatment of bipolar disorder.

In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...

Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...

About 120 drugs have lost or will lose patent protection in 2013. EvaluatePharma estimates that this accounts for nearly $29 billion in total annual revenue, a number which will grow ten-fold between ...

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...

Mark Cuban Cost Plus Drug Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Alex Oshmyansky, M.D., Ph.D., said Monday during a ...

Antiretroviral drugs are one of the pharmaceutical industry’s great achievements. They have turned HIV/AIDS from a death sentence into a treatable condition. Still, even after being on the market for ...

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...